United Kingdom · Series A startup

Who invested in Dunad Therapeutics

3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$38Mraised across 3 rounds since 2021, from 3 sources

$24MSeries A$13MRound$547KRound
Latest round
Round, $547KMay 2025
Biggest round
$24MSeries A · Nov 2021
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2022202320242025
$24MSeries A$13MRound$547KRound
First round
Series A, $24M
Nov 2021
Biggest round
$24M
Series A · Nov 2021
Usual gap between rounds
2.8 years
the median of 2

The rounds

  1. May 2025
    Round$547K

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  2. Aug 2024
    Round$13M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  3. Nov 2021
    Series A$24M1 new

    Source recorded

Funding filed with regulators

Dunad Therapeutics filed 3 raises, $27M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. May 2025$547KUK share allotment
  2. Aug 2024$13MUK share allotment
  3. Oct 2021$13MUK share allotment

Everyone who backed them

NovartisVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Dunad Therapeutics

Who invested in Dunad Therapeutics?

Dunad Therapeutics's investors include Novartis.

How much has Dunad Therapeutics raised?

Dunad Therapeutics has raised $38M across 3 rounds since 2021.

When did Dunad Therapeutics last raise?

Dunad Therapeutics's most recent round, $547K, was in May 2025.

What was Dunad Therapeutics's biggest round?

Dunad Therapeutics's largest round on record is $24M (Series A), in Nov 2021.

Who backed Dunad Therapeutics first?

Dunad Therapeutics's first round on record, in Nov 2021, was backed by Novartis.

What stage is Dunad Therapeutics at?

Dunad Therapeutics's latest named round is a Series A, in Nov 2021.

Where is Dunad Therapeutics based?

Dunad Therapeutics is based in the United Kingdom.

Companies like Dunad Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.